Insmed, Inc. (INSM)
124.03
-1.74
(-1.38%)
USD |
NASDAQ |
Aug 24, 16:00
124.03
0.00 (0.00%)
After-Hours: 20:00
Insmed Profit Margin (Quarterly) : -3.11% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.11% |
| March 31, 2026 | -53.46% |
| December 31, 2025 | -124.5% |
| September 30, 2025 | -260.0% |
| June 30, 2025 | -299.5% |
| March 31, 2025 | -276.4% |
| December 31, 2024 | -225.5% |
| September 30, 2024 | -236.0% |
| June 30, 2024 | -332.8% |
| March 31, 2024 | -208.1% |
| December 31, 2023 | -222.3% |
| September 30, 2023 | -201.0% |
| June 30, 2023 | -317.0% |
| March 31, 2023 | -245.0% |
| December 31, 2022 | -270.0% |
| September 30, 2022 | -193.6% |
| June 30, 2022 | -146.6% |
| March 31, 2022 | -178.2% |
| December 31, 2021 | -201.3% |
| September 30, 2021 | -241.1% |
| June 30, 2021 | -258.6% |
| March 31, 2021 | -227.9% |
| December 31, 2020 | -246.8% |
| September 30, 2020 | -145.9% |
| June 30, 2020 | -145.6% |
| Date | Value |
|---|---|
| March 31, 2020 | -180.0% |
| December 31, 2019 | -115.9% |
| September 30, 2019 | -156.1% |
| June 30, 2019 | -221.9% |
| March 31, 2019 | -338.6% |
| December 31, 2018 | -931.1% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| United Therapeutics Corp. | 42.51% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Biogen, Inc. | 3.72% |
| Gilead Sciences, Inc. | -134.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -99.54% |
| Return on Assets | -38.79% |
| Return on Invested Capital | -53.79% |
| Gross Profit Margin (Quarterly) | 83.71% |
| Operating Margin (Quarterly) | -23.81% |
| Return on Net Operating Assets | -144.0% |